Redness, swelling, or pain at the injection site
wound care protocols may be extended at physician discretion based on healing response Administration Subcutaneous injection for systemic wound healing, post-surgical recovery, and combination protocols
Human pharmacokinetics, doseresponse, and mechanism validation remain limited
Acute toxicity studies have failed to establish a lethal dose even at very high concentrations in rodents, a finding reported by the Sikiric group and referenced in several reviews
At GWCIM, we offer NAD+ as an intramuscular injection rather than an IV infusion
Inflammation balance Animal data report downregulation of NF-kB and Nos2 in injury settings